Characterization of all RND-type multidrug efflux transporters in Vibrio parahaemolyticus

Bacterial strains and growth

The bacterial strains and plasmids used in this study are listed in Table 1. V. parahaemolyticus RIMD2210633 was obtained from Osaka University. Bacterial cells were grown in LB medium at 37°C. Antimicrobial agents were added to the medium, as necessary. The growth of cells was monitored by measuring optical density at 650 nm.

Construction of a plasmid library containing putative RND-type multidrug efflux transporter ORFs

Open reading frames (ORFs) assumed to be RND-type multidrug efflux transporter genes were cloned from the chromosomal DNA of V. parahaemolyticus RIMD2210633. ORFs were amplified without putative native promoters by polymerase chain reaction (PCR) using the pair of primers shown in Table 2. The putative outer membrane protein gene, VPA0362 (designated vpoM), was amplified with a membrane fusion protein gene (VPA0364, vmeN) and inner membrane protein gene (VPA0363, vmeO) because vpoM appears to form an operon with vmeN and vmeO under the control of a promoter upstream of vmeN. PCR was performed with a PTC-100™ Programmable Thermal Controller (MJ Research Inc., Quebec, Canada) using KOD -plus- DNA polymerase (TOYOBO Co., Ltd, Kita-ku, Osaka, Japan). PCR products were confirmed with 1% agarose gel electrophoresis and purified by the GENECLEAN II kit (MP Biomedicals Japan, Chuo-ku, Tokyo, Japan). DNA fragments were digested with a restriction enzyme and then ligated at the multicloning sites of pSTV28 or pSTV29 (TAKARA BIO Inc., Otsu, Shiga, Japan). All RND multidrug efflux transporter genes were ligated under the lac promoter of pSTV vectors. E. coli KAM33 competent cells were transformed with recombinant plasmids. The nucleotide sequences of ORFs in recombinant plasmids were determined by the dideoxy chain termination method, and were confirmed to match sequences in the database (http://genome.naist.jp/bacteria/vpara/).

Construction of pBET2 carrying the tolC of E. coli

A XbaI-FspI fragment from the pSET2 plasmid (Li et al. 2008) carrying the tolC gene was ligated to pBR322 digested with NheI and NruI. The resulting plasmid was named pBET2. The inserted tolC gene without a native promoter region was located downstream of the tet promoter of the same orientation.

Drug susceptibility test

The MICs of various antimicrobial agents were determined in Mueller–Hinton broth (BD Japan, Minato-ku, Tokyo, Japan) containing different drugs at various concentrations as described previously (Matsuo et al. 2007). In order for cloned genes to be expressed, 0.5 mmol/L isopropyl-β-D-thiogalactopyranoside (IPTG) was added as necessary. Cells were incubated in the test medium at 37°C for 24 h, and growth was examined by visual inspection. MIC was defined as the lowest concentration of a drug that inhibited visible growth.

RT-PCR analysis

Total RNA was extracted from the cells of V. parahaemolyticus AQ3334 and RIMD2210633 grown in LB medium or LB medium containing 0.2% sodium deoxycholate at the exponential phase with the QIAGEN RNeasy Mini Kit (QIAGEN, Chuo-ku, Tokyo, Japan). Extracted total RNA was treated with RNase-free DNase (Promega KK, Chuo-ku, Tokyo, Japan) and re-purified using the same kit. Reverse transcription polymerase chain reaction (RT-PCR) was performed with the QIAGEN One-Step RT-PCR Kit (QIAGEN Inc.). PCR without a reverse transcription reaction was performed to confirm the absence of detectable DNA contamination. RT-PCR products were analyzed by 3% agarose X gel (NIPPON GENE CO., LTD., Chiyoda-ku, Tokyo, Japan) electrophoresis. Primers used for RT-PCR are described in Table 2. The amplification efficacy of each primer set was compared using chromosomal DNA as a template (data not shown).

Ethidium efflux assay

Ethidium efflux assays were performed as described previously with a slight modification (Rahman et al. 2007). In brief, E. coli KAM43 cells harboring both pBVT3 (carrying vpoC) and pSTV28 (empty vector), and E. coli KAM43 cells harboring both pBVT3 and either pSVP201 (carrying vmeCD) or pSVP202 (carrying vmeEF) were grown in LB broth supplemented with 100 μg mL⁻¹ of ampicillin and 20 μg mL⁻¹ of chloramphenicol with 40 mmol/L potassium lactate and 0.5 mmol/L IPTG at 37°C up to the late exponential phase of growth. Cells were harvested and washed twice with modified Tanaka medium (Tanaka et al. 1967) in which sodium salts were replaced with potassium salts and supplemented with 2 mmol/L MgSO₄. Cells were resuspended in the same buffer including 10 μmol/L ethidium bromide and 40 μmol/L carbonylcyanide m-chlorophenylhydrazone (CCCP) to starve energy and load ethidium, and were incubated at 37°C for 1 h. Cells were harvested and washed twice with the same buffer containing 10 μmol/L of ethidium bromide and 2 mmol/L MgSO₄. Potassium lactate (40 mmol/L) was added for energization. The fluorescence intensity of ethidium was measured at an excitation wavelength of 500 nm and emission wavelength of 580 nm, respectively, using an F-2000 Fluorescence Spectrophotometer (Hitachi, Ltd., Chiyoda-ku, Tokyo, Japan).

V. parahaemolyticus cells were grown in LB broth supplemented with 40 mmol/L potassium lactate, and washed twice with Medium S (50 mmol/L Tris-HCl, 200 mmol/L NaCl, 25 mmol/L MgSO₄, 10 mmol/L (NH₄)₂SO₄, 10 mmol/L KCl, 1 mmol/L CaCl₂, 0.33 mmol/L K₂HPO₄, 10 μmol/L FeSO₄, pH 7.5). Cells were incubated in Medium S including 10 μmol/L ethidium bromide and 40 μmol/L CCCP at 37°C for 1 h. Cells were harvested and washed twice with the same buffer containing 10 μmol/L of ethidium bromide. Potassium lactate (40 mmol/L) was added for energization.

Gene disruption by homologous recombination

Gene disruption was accomplished in V. parahaemolyticus as described previously (Kuroda et al. 2005; Matsuo et al. 2007). In brief, the plasmids pXAC1092, pXAC0038, pXAC0941, pXAC1178, pXAC2472, pXAC0344, pXAC0363, pXAC0471, pXAC0480, pXAC0809, pXAC0944, pXAC1190, and pXAC0425 were constructed, and each of these plasmids carried each inactivated operon vmeAB, vmeCD, vmeEF, vmeGHI, vmeJK, vmeLM, vmeNO, vmePQ, vmeRS, vmeTUV, vmeWX, vmeYZ, and vpoC, respectively. Each plasmid was introduced into E. coli β2155 (Herz et al. 2003). These donor strains harboring each plasmid, carrying the deleted RND type genes, and recipient strains were harvested at the early exponential phase of growth and mixed gently. The mixed cell suspension was trapped on a membrane filter (0.2 μm pore size, Toyo Roshi Kaisha, Ltd., Bunkyo-ku, Tokyo, Japan). After washing, the filter was put on an LB broth agar plate and incubated at 37°C for 3 h. Cells were suspended in LB broth and shaken at 37°C for 1 h. The cell suspension was spread onto an LB broth agar plate (2.5% agar for vibrio) containing 5 μg mL⁻¹ chloramphenicol and 50 μg mL⁻¹ ampicillin. Ampicillin was added to allow only V. parahaemolyticus cells to grow. The plate was incubated at 30°C overnight. Chloramphenicol-resistant and ampicillin-resistant candidates were picked and used for the next step. These candidates were cultured in LB broth without any antibiotics, spread onto a VDS agar plate (1% polypeptone, 0.5% yeast extract, 30 mmol/L NaCl, 55 mmol/L KCl, 10% sucrose, and 2.5% agar), and incubated at 25°C or below. When a second recombination occurred, cells were expected to become resistant to sucrose and sensitive to chloramphenicol. By amplifying the corresponding gene region with PCR, we confirmed that genes were disrupted.

Effect of sodium deoxycholate on the survival rate of V. parahaemolyticus strains

V. parahaemolyticus cells in the exponential phase (2.72–7.37 × 10⁶ cells) were suspended in 1 mL of 0.5 mol/L NaCl-PB (0.1 mol/L phosphate buffer, pH 7.2) including 1 mg mL⁻¹ of sodium deoxycholate. After incubation at 37°C for 10 min, cells diluted 10⁻⁴ with 0.5 mol/L NaCl-PB were spread onto an LB agar plate (2.5% agar). Colony-forming units were counted following incubation at 37°C for 12 h. Three individual experiments were performed and similar results were obtained.

Rabbit ileal loop test

The rabbit ileal loop test was performed as described previously (Hiyoshi et al. 2010). Isogenic mutant strains of V. parahaemolyticus (10⁹ CFU/loop) were injected into the ligated rabbit ileal loop followed by the measurement of fluid accumulation in each loop 18 h after the injection. Fluid accumulation (FA) ratios were calculated as the amount of accumulated fluid (mL) per length (cm) of ligated rabbit small intestine. All animal experiments were performed according to the experimental protocol approved by the Ethics Review Committee for Animal Experimentation of the Research Institute for Microbial Diseases (Osaka University, Osaka, Japan).

CAS assay

The preparation of chrome azurol S (CAS) solution and the CAS assay were performed as described previously (Schwyn and Neilands 1987). Bacterial cells were grown in LB medium to the late exponential phase of growth under aerobic conditions at 37°C. Cells were harvested and washed twice with medium SF with no FeCl₃ in Medium S, were inoculated into the same medium containing 0.2% glucose at an optical density of 650 nm (O.D.₆₅₀) of 0.5, and were shaken at 37°C. Growth was monitored by measuring O.D.₆₅₀. A 35 μL aliquot of supernatant was mixed with 70 μL CAS assay solution. The mixture was incubated at room temperature for 2 h, and the absorbance was then measured at 630 nm.

Search for RND-type efflux transporter genes in the V. parahaemolyticus RIMD2210633 genome

Twelve operons for RND-type multidrug efflux transporters were estimated to be present according to the genome sequence of V. parahaemolyticus RIMD2210633 (http://genome.naist.jp/bacteria/vpara/). One of them, VmeAB, has already been characterized (Matsuo et al. 2007). We designated the other genes and they are shown in Figure 1. MFP genes were located upstream of each IMP gene except for vmeW. The MFP gene, vmeX, was located downstream of vmeW. Two consecutive MFP genes were located upstream of vmeI and vmeV. One OMP gene, designated vpoM, was located downstream of vmeO.

Cloning of RND-type multidrug efflux transporter genes and analysis in E. coli cells

Among these 12 operons, only vmeAB has already been cloned (Matsuo et al. 2007). We cloned the other 11 operons into multicopy plasmids at the downstream position of the lac promoter (without a putative original promoter) to achieve their effective and definite expression in E. coli cells (Table 1). These recombinant plasmids were introduced into drug-hypersusceptible E. coli KAM33 (Matsuo et al. 2007; Rahman et al. 2007), and we then investigated whether the introduction of these genes elevated drug resistance in host cells (Table 3). Three of them, VmeCD (pSVP201), VmeEF (pSVP202), and VmeYZ (pSVP212), conferred elevated drug resistance on E. coli KAM33 cells. Fold increases by VmeCD, in particular, on the MICs of SDS and bile acids were very high (SDS: >512-fold and bile acids: >32-fold). VmeEF conferred the elevated MIC of ethidium bromide (twofold) only. VmeYZ conferred high resistance to SDS (>512-fold), taurocholate (>eightfold), and glycocholate (>eightfold). The other eight plasmids did not render any increased resistance to the antimicrobial agents tested.

RND-type efflux transporters have been shown to consist of three components; IMP, OMP, and MFP. No OMP gene has been identified downstream of each operon, except for vmeNO-vpoM. The above three RND-type efflux transporters, VmeCD, VmeEF, and VmeYZ, which conferred drug resistance on E. coli cells, appeared to utilize TolC as an OMP component in E. coli. These efflux transporters could not elevate drug-resistant levels in E. coli KAM43, which is a tolC deletion mutant of KAM33 (data not shown). We previously reported that VmeAB could utilize VpoC, which is a TolC-like outer membrane protein in V. parahaemolyticus that confers similar drug resistant levels to E. coli cells (Matsuo et al. 2007). We investigated whether the other 11 RND-type efflux transporters could utilize VpoC as an OMP component. We measured the MICs of various drugs to E. coli KAM43 harboring both pBVT3 carrying vpoC and each RND-type efflux transporter gene recombinant plasmid (Table 4, upper panel). Interestingly, additional four recombinant plasmids (pSVP204, pSVP205, pSVP206, and pSVP210) conferred drug resistance on E. coli cells. These results suggested that VmeGHI, VmeJK, VmeLM, and VmeTUV formed functional complexes with the VpoC of V. parahaemolyticus. Furthermore, VmeCD-VpoC, VmeEF-VpoC, and VmeYZ-VpoC conferred higher resistance than VmeCD-TolC, VmeEF-TolC, and VmeYZ-TolC, respectively. VmeEF-VpoC and VmeYZ-VpoC complexes conferred resistance to not only bile acids such as cholate and taurocholate but also to some antibiotics and dyes. VmeCD-VpoC conferred high resistance to various drugs. Therefore, complexes with VpoC can extrude various antimicrobial agents more effectively than complexes with TolC.

VpoC was expressed from the multicopy plasmid while TolC was expressed from the chromosome. Therefore, the expression of outer membrane components may affect the activity of RND-type efflux transporters. We measured MICs of several drugs to KAM43 harboring pBET2, carrying the tolC of E. coli, and the recombinant plasmid carrying each RND-type efflux transporter gene of V. parahaemolyticus. However, the MICs of KAM43/pBET2 harboring each recombinant plasmid were similar to those of KAM33 harboring each recombinant plasmid (Table 4, lower panel). Therefore, we concluded that the RND-type efflux transporters of V. parahaemolyticus could utilize VpoC better than TolC.

We measured ethidium efflux via VmeCD-VpoC and VmeEF-VpoC in E. coli cells. The fluorescence of ethidium has been shown to increase when it binds to DNA inside the cell. Therefore, the efflux of ethidium can be detected as a decrease in fluorescence intensity (LePecq and Paoletti 1967). After the addition of potassium lactate to energy-starved and ethidium-preloaded cells, E. coli expressing VmeCD-VpoC had significantly lower intracellular ethidium levels than those of the control cells expressing only VpoC (Fig. 2). In the case of E. coli expressing VmeEF-VpoC, intracellular ethidium levels were slightly but reproducibly decreased. These results suggest that VmeCD-VpoC and VmeEF-VpoC are energy-dependent drug efflux transporters.

RT-PCR analysis of the RND-type efflux transporter genes

We investigated the expression of 12 RND-type efflux transporter genes in V. parahaemolyticus AQ3334 using the RT-PCR method. The expression of vmeB, vmeD, vmeI, and vmeW was relatively abundant among the 12 RND-type efflux transporter genes (Fig. 3A). In contrast, the expression of vmeO, vmeQ, and vmeS was low. The expression pattern of RND-type efflux transporter genes in V. parahaemolyticus RIMD2210633 was similar to that in AQ3334 (data not shown).

The expression of both vexAB and vexCD, which encode RND-type efflux transporters, in V. cholerae was shown to be upregulated in response to bile acids (Bina et al. 2006). We tested whether the expression of the 12 RND-type efflux transporter genes was influenced by bile acids. The RT-PCR results showed that the expression of vmeD was upregulated in response to deoxycholate, which is one of the constituents of bile acids (Fig. 3B). The putative TetR family transcriptional regulator gene, VP0040, was located upstream of vmeC. This regulator protein encoded by VP0040 may be involved in the transcriptional regulation of vmeCD. The transcription of other RND-type efflux transporter genes was not affected by deoxycholate (data not shown).

Role of RND-type efflux transporters in intrinsic resistance to various antimicrobial agents in V. parahaemolyticus

We previously showed that VmeAB conferred high resistance to various drugs and bile acids on E. coli KAM33 cells. However TM3, which is the vmeAB deletion mutant from V. parahaemolyticus AQ3334, had slightly lower resistance levels to various drugs than that of AQ3334 (Matsuo et al. 2007). To investigate the contributions of other RND-type efflux transporters to the intrinsic resistance of V. parahaemolyticus, we constructed deletion mutants of the V. parahaemolyticus AQ3334 strain lacking the RND-type efflux transporter genes (Table 1). TM4 (ΔvmeCD), in addition to TM3 (ΔvmeAB), had slightly increased susceptibility to the several antimicrobial agents tested. However, other single deletion mutants showed the same susceptibility as AQ3334 (Table 5).

Most single deletions had no effect on drug susceptibility even if some deleted genes conferred drug resistance when expressed in E. coli cells. The effect of a single gene deletion may be masked by other efflux systems. Therefore, we constructed multiple gene disruption strains (Table 1). We also constructed TM312, in which all of the 12 RND-type efflux transporter genes are deleted, and investigated the drug susceptibilities of these mutants (Table 5). We investigated growth rates before any of the experiments were conducted. Under our experimental conditions, all of the deletion strains showed comparative growth rates.

Double disruptant TM32 (ΔvmeAB, ΔvmeCD) showed higher susceptibility than TM3 to many antimicrobial agents, such as cloxacillin (16-fold), erythromycin (16-fold), novobiocin (fourfold), ethidium bromide (eightfold), rhodamine 6G (16-fold), tetraphenylphosphonium chloride (TPPCl) (fourfold), sodium dodecyl sulfate (SDS) (128-fold), sodium cholate (CHO) (more than 16-fold), and sodium deoxycholate (DEO) (eightfold). The triple deletion strain TM33 with vmeEF deleted was more susceptible than parental TM32 to oxacillin (twofold), novobiocin (fourfold), ethidium bromide (twofold), SDS (twofold), and CHO (twofold). TM34 with vmeYZ deleted was more susceptible than TM33 to cloxacillin (fourfold), chlorhexidine (twofold), and sodium glycocholate (GLY) (more than 32-fold). Moreover, TM37 with vmeJK, vmeGHI, and vmeTUV deleted was more susceptible to benzalkonium chloride (twofold), chlorhexidine (twofold), rhodamine 6G (fourfold), SDS (fourfold), CHO (twofold), and DEO (eightfold). Deletion of the remaining RND-type efflux transporter genes (vmeLM, vmeNO, vmePQ, vmeRS, and vmeWX) from TM37 did not increase susceptibility to any of the antimicrobial agents tested. These results suggest that at least seven transporters (VmeAB, VmeCD, VmeEF, VmeYZ, VmeJK, VmeGHI, and VmeTUV) are functional and contribute to intrinsic resistance in V. parahaemolyticus against several antimicrobial agents.

We also constructed the vpoC deletion mutant TM15 from V. parahaemolyticus AQ3334. TM15 showed similar substrate specificity profiles to TM312, which suggests that the RND-type efflux transporters that are involved in the intrinsic resistance of V. parahaemolyticus require VpoC as an OMP component. Furthermore, TM15 had higher susceptibility to oxacillin and cloxacillin than that of TM312, which indicates that efflux systems, except the RND-type efflux transporter, exist in V. parahaemolyticus and interact with VpoC.

We measured the efflux of ethidium in V. parahaemolyticus AQ3334 and its derivatives. V. parahaemolyticus AQ3334 exhibited strong efflux after the addition of potassium lactate (Fig. 4A). TM3 and TM4, lacking either vmeAB or vmeCD, showed similar effluxes to the parental strain AQ3334. However, marked decreases in ethidium efflux were observed in TM32 lacking both vmeAB and vmeCD. Efflux was less by the triple disruptant TM33 than by TM32. TM34 and TM312 showed similar effluxes to TM33 (data not shown). These results suggest that a deficiency in one efflux transporter is complemented by another efflux transporter, which corresponds to the results of the drug susceptibility test.

Characterization of RND-type efflux transporters in V. parahaemolyticus cells

To characterize each RND-type efflux transporter in V. parahaemolyticus, we introduced recombinant plasmids carrying each RND-type efflux transporter gene into V. parahaemolyticus TM312, and investigated drug susceptibility (Table 6). The introduction of pRHR228 (vmeAB) and pSVP201 (vmeCD) conferred drug resistance to many antimicrobial agents on V. parahaemolyticus TM312 cells, and its substrate profiles were similar to those of E. coli cells (Table 3). The introduction of either VmeAB or VmeCD by itself could restore drug resistance to wild type levels. Interestingly, some RND-type efflux transporters exhibited substrate specificity profiles in V. parahaemolyticus cells that differ from those in E. coli cells. pSVP205 (vmeJK) and pSVP206 (vmeLM) were shown to newly confer drug resistance to rhodamine 6G and bile acids, respectively. Although none of the RND type efflux transporters exhibited elevated resistance to chlorhexidine in E. coli cells, VmeAB, VmeCD, VmeGHI, and VmeTUV conferred drug resistance to chlorhexidine in V. parahaemolyticus cells. Furthermore, pSVP208 (vmePQ) conferred drug resistance to SDS and bile acids on V. parahaemolyticus cells, whereas the plasmid did not confer any resistance on E. coli cells.

Previous studies showed that MexJK required OprM and OpmH as OMP components for erythromycin efflux and triclosan efflux in P. aeruginosa, respectively (Chuanchuen et al. 2002, 2005). Therefore, we attempted to identify any OMP component, except for VpoC, required in V. parahaemolyticus. Recombinant plasmids carrying each RND transporter gene were introduced into TM425, which is the deleted vpoC gene from TM312. No RND-type efflux pumps elevated resistance to any antimicrobial agent (data not shown). Nine RND-type efflux transporters, which conferred drug resistance on V. parahaemolyticus TM312, were suggested to utilize only VpoC as an OMP component.

We also measured the efflux of ethidium in V. parahaemolyticus TM312 cells harboring pRHR228 (vmeAB), pSVP201 (vmeCD), pSVP202 (vmeEF), pSVP204 (vmeGHI), and pSVP210 (vmeTUV), which conferred ethidium resistance on TM312. As shown in Figure 4B, the energy-dependent efflux of ethidium from V. parahaemolyticus TM312 cells harboring each plasmid was observed as a decrease in fluorescence. Because the control cells of TM312/pSTV28 showed very low ethidium efflux activity, VmeAB, VmeCD, VmeEF, VmeGHI, and VmeTUV were suggested to possess the efflux ability of ethidium.

Physiological properties of RND-type efflux transporter disruptants

The ΔvmeAB strain showed slight sensitivity to deoxycholate; therefore, VmeAB was considered to contribute to resistance to deoxycholate (Matsuo et al. 2007). The MIC for deoxycholate revealed that at least eight RND-type efflux transporters conferred resistance to sodium deoxycholate. We next investigated the effect of sodium deoxycholate on V. parahaemolyticus gene deletion mutants. The percentage of viable AQ3334 cells exposed to 1 mg mL⁻¹ sodium deoxycholate was reduced to 16%. In contrast, TM3 (ΔvmeAB) and TM4 (ΔvmeCD) showed 83% and 99.9% reductions in survival rates, respectively (Table 7). Viable cells of the TM32 and TM312 strains treated with deoxycholate were not detected in our experimental conditions. These results suggest that VmeCD is the main efflux transporter with roles in the resistance to deoxycholate, with VmeAB being the next contributor.

Fluid accumulation was compared in rabbit ileal loops to evaluate the contribution of RND-type efflux transporters to its pathogenicity. The V. parahaemolyticus RIMD2210633 strain was used in this experiment because this strain was shown to have the ability to cause fluid accumulation (Gotoh et al. 2010). All 12 RND-type efflux transporter genes were deleted from RIMD2210633, and it was subsequently designated as RTM313. The MIC values of RTM313 were almost the same as those of TM312 (data not shown). Fluid accumulation was significantly lower with RTM313 than with RIMD2210633 (Fig. 5), which indicates that RND-type efflux transporters are involved in the pathogenicity of V. parahaemolyticus.

We next investigated the production of siderophores, which bind ferric ions and are important for the uptake of iron. MexAB was shown to be involved in the secretion of pyoverdine, a siderophore in P. aeruginosa, and V. parahaemolyticus was also shown to produce the polyhydroxycarboxylate-type siderophore, vibrioferrin under iron-limiting conditions (Yamamoto et al. 1994). Vibrioferrin production was higher by the V. parahaemolyticus RIMD2210633 strain than by the AQ3334 strain (data not shown). Therefore, RIMD2210633 and its derivatives were used to investigate vibrioferrin production. The CAS assay revealed that extracellular vibrioferrin was significantly decreased in RTM313 (Fig. 6), which suggests that some RND-type efflux transporters are important for vibrioferrin export or production.

We also investigated cell morphology and biofilm formation. No significant morphological changes were observed between TM312 and wild type cells (data not shown). We used V. parahaemolyticus RIMD2210633 and its derivatives for the biofilm formation assay because V. parahaemolyticus AQ3334 could not form biofilms under our experimental conditions (data not shown). The deletion of any RND-type efflux transporter had no significant effect on biofilm formation (data not shown).